United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Oct 14, 2026 · Filed Oct 15, 2026

On Oct 14, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$539.99 for US$5.13M under a trading plan, leaving 324,443 shares. Filed Oct 15, 2026 (Form 4).

Sold
9,500 shares
Price
US$539.99 average (US$526.07 to US$546.00)
Value
US$5.13M
Holding after
324,443 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Oct 14, 2026Common StockOption exercise9,500US$117.76333,943Indirect
Oct 14, 2026Common StockSale40US$526.07333,903Indirect
Oct 14, 2026Common StockSale160US$530.09333,743Indirect
Oct 14, 2026Common StockSale120US$531.19333,623Indirect
Oct 14, 2026Common StockSale40US$532.48333,583Indirect
Oct 14, 2026Common StockSale240US$534.63333,343Indirect
Oct 14, 2026Common StockSale400US$535.89332,943Indirect
Oct 14, 2026Common StockSale633US$537.19332,310Indirect
Oct 14, 2026Common StockSale1,127US$538.00331,183Indirect
Oct 14, 2026Common StockSale525US$539.09330,658Indirect
Oct 14, 2026Common StockSale2,002US$540.23328,656Indirect
Oct 14, 2026Common StockSale1,930US$541.20326,726Indirect
Oct 14, 2026Common StockSale883US$542.07325,843Indirect
Oct 14, 2026Common StockSale400US$543.15325,443Indirect
Oct 14, 2026Common StockSale480US$544.35324,963Indirect
Oct 14, 2026Common StockSale480US$545.48324,483Indirect
Oct 14, 2026Common StockSale40US$546.00324,443Indirect

Source

Download original · View original at SEC

Related